Previous close | 5,531.00 |
Open | 5,577.00 |
Bid | 5,494.00 x N/A |
Ask | 5,498.00 x N/A |
Day's range | 5,487.00 - 5,596.00 |
52-week range | 3,566.00 - 5,596.00 |
Volume | |
Avg. volume | 4,302,131 |
Market cap | 10.539T |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 52.57 |
EPS (TTM) | 104.54 |
Earnings date | 29 July 2024 - 02 Aug 2024 |
Forward dividend & yield | 60.00 (1.08%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | 5,792.30 |
This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
TOKYO & BASKING RIDGE, N.J., April 29, 2024--ENHERTU Showed Statistically Significant & Clinically Meaningful Improvement in PFS in HR Positive, HER2 Low mBC Following ET in DESTINY-Breast06
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.